Φορτώνει......
Unexpected neurologic complications following a novel lymphoma treatment ‘expected’ to give rise to neurologic toxicity
Chimeric antigen receptor (CAR) T-cell therapy is a novel and promising form of cellular immunotherapy using genetically engineered, tumour-specific autologous T cells. CD19-specific CAR T-cells have been shown to be very effective as a treatment for relapsed/refractory B-cell acute lymphoblastic le...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMJ Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMJ Publishing Group
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855863/ https://ncbi.nlm.nih.gov/pubmed/31722870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229946 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|